{"paper":{"title":"A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"A question-driven workflow with targeted statistical methods supports exploratory checks for regional treatment differences in multi-regional trials.","cross_cats":["stat.ME"],"primary_cat":"stat.AP","authors_text":"Bj\\\"orn Bornkamp, Cong Zhang, Konstantinos Sechidis, Meihua Long, Shuhei Kaneko, Sophie Sun, Tianyu Zheng, Xiaoni Liu, Xinyi Zhang, Yan Hou, Yao Chen","submitted_at":"2026-05-16T08:58:35Z","abstract_excerpt":"Multi-regional clinical trials (MRCTs) enable efficient global drug development by assessing treatment effects across regions within a single protocol. While powered for overall efficacy, MRCTs are typically not designed to provide confirmatory evidence on regional differences, making an assessment of observed regional heterogeneity largely exploratory and susceptible to sampling variability. Despite this challenge, understanding regional heterogeneity remains important for interpretation and regulatory decision-making. This paper proposes a structured, question-driven framework to guide explo"},"claims":{"count":4,"items":[{"kind":"strongest_claim","text":"This paper proposes a structured, question-driven framework to guide exploratory assessments of regional heterogeneity in MRCTs, with a set of statistical methods to address four key questions, supported by simulation studies under scenarios with no heterogeneity and heterogeneity driven by observed or unobserved treatment effect modifiers.","source":"verdict.strongest_claim","status":"machine_extracted","claim_id":"C1","attestation":"unclaimed"},{"kind":"weakest_assumption","text":"That formulating four key questions sufficiently clarifies the objectives of regional heterogeneity analyses and that the proposed statistical methods can support transparent and cautious interpretation even when the trial is not powered for regional differences.","source":"verdict.weakest_assumption","status":"machine_extracted","claim_id":"C2","attestation":"unclaimed"},{"kind":"one_line_summary","text":"The paper introduces a question-driven framework and set of statistical methods for exploratory assessment of regional treatment effect heterogeneity in multi-regional clinical trials, evaluated via simulations under no-heterogeneity and modifier-driven scenarios.","source":"verdict.one_line_summary","status":"machine_extracted","claim_id":"C3","attestation":"unclaimed"},{"kind":"headline","text":"A question-driven workflow with targeted statistical methods supports exploratory checks for regional treatment differences in multi-regional trials.","source":"verdict.pith_extraction.headline","status":"machine_extracted","claim_id":"C4","attestation":"unclaimed"}],"snapshot_sha256":"488904bcfa3cd69b61dc34c8e324affd77ccab30cc4897da8a0859289a073e7c"},"source":{"id":"2605.16885","kind":"arxiv","version":1},"verdict":{"id":"11d621b4-e283-4a94-99b7-d4d561ca8154","model_set":{"reader":"grok-4.3"},"created_at":"2026-05-19T19:18:44.697149Z","strongest_claim":"This paper proposes a structured, question-driven framework to guide exploratory assessments of regional heterogeneity in MRCTs, with a set of statistical methods to address four key questions, supported by simulation studies under scenarios with no heterogeneity and heterogeneity driven by observed or unobserved treatment effect modifiers.","one_line_summary":"The paper introduces a question-driven framework and set of statistical methods for exploratory assessment of regional treatment effect heterogeneity in multi-regional clinical trials, evaluated via simulations under no-heterogeneity and modifier-driven scenarios.","pipeline_version":"pith-pipeline@v0.9.0","weakest_assumption":"That formulating four key questions sufficiently clarifies the objectives of regional heterogeneity analyses and that the proposed statistical methods can support transparent and cautious interpretation even when the trial is not powered for regional differences.","pith_extraction_headline":"A question-driven workflow with targeted statistical methods supports exploratory checks for regional treatment differences in multi-regional trials."},"integrity":{"clean":false,"summary":{"advisory":0,"critical":1,"by_detector":{"doi_compliance":{"total":1,"advisory":0,"critical":1,"informational":0}},"informational":0},"endpoint":"/pith/2605.16885/integrity.json","findings":[{"note":"DOI '10.1002/sim.xxxx' as printed in the bibliography is syntactically invalid and cannot resolve.","detector":"doi_compliance","severity":"critical","ref_index":71,"audited_at":"2026-05-19T19:30:59.960240Z","detected_doi":"10.1002/sim.xxxx","finding_type":"broken_identifier","verdict_class":"incontrovertible","detected_arxiv_id":null}],"available":true,"detectors_run":[{"name":"doi_title_agreement","ran_at":"2026-05-19T19:31:18.966081Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"doi_compliance","ran_at":"2026-05-19T19:30:59.960240Z","status":"completed","version":"1.0.0","findings_count":1},{"name":"claim_evidence","ran_at":"2026-05-19T18:41:56.287671Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"ai_meta_artifact","ran_at":"2026-05-19T18:33:26.365482Z","status":"skipped","version":"1.0.0","findings_count":0}],"snapshot_sha256":"740886af882979ccfbcd3439982c1935ef2ac368944ade819ea97eed896e8471"},"references":{"count":72,"sample":[{"doi":"10.1001/jama.1991.03470010097038","year":1991,"title":"Yusuf, Salim and Wittes, Janet and Probstfield, Jeffrey and Tyroler, Herman A. , title = \". JAMA , volume =. 1991 , month =. doi:10.1001/jama.1991.03470010097038 , url =","work_id":"6caf6a06-fd65-4265-98de-b0e70a57b152","ref_index":1,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"10.1001/jamainternmed.2016.9125","year":2017,"title":"and Sullivan, Patrick G","work_id":"bac7b77d-82ce-4f06-8829-93020e571ec8","ref_index":2,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":null,"title":"Regression and Other Stories , publisher=","work_id":"1cb148d9-82c5-4fbc-8949-a6cabcb71727","ref_index":3,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"10.1002/pst.1648","year":null,"title":"Bretz, Frank and Westfall, Peter H. , title =. Pharmaceutical Statistics , volume =. doi:10.1002/pst.1648 , url =. https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.1648 , year =","work_id":"dc526ec8-1b34-419a-b091-49c6f797a013","ref_index":4,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"10.1002/pst.2110","year":null,"title":"Ruberg, Stephen J. , title =. Pharmaceutical Statistics , volume =. doi:10.1002/pst.2110 , url =. https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2110 , abstract =","work_id":"2daee452-569f-4e66-8792-2c3b049cd00d","ref_index":5,"cited_arxiv_id":"","is_internal_anchor":false}],"resolved_work":72,"snapshot_sha256":"b1a363d2095123fae9c2ebd369773178c4f9290b2f68afa5e6995b5aa976d4e8","internal_anchors":1},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"}